Systemic neoantigen-specific T cells reveal central determinants of PD-(L)1 blockade efficacy
Célia Ramade, Noémie Thébault, Clara‐Maria Scarlata…·Maha Ayyoub
The paper identifies coordinated neoantigen-specific CD8 T cell responses as key predictors of PD-(L)1 therapy efficacy in non-small cell lung cancer patients.